UNSPSC 85642190: Supplement of right upper arm subcutaneous tissue and fascia with nonautologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement of right upper arm subcutaneous tissue and fascia with nonautologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0JUD3KZ

UNSPSC 85642190 Supplement of right upper arm subcutaneous tissue and fascia with nonautologous tissue substitute, percutaneous approach is a Commodity code that shows minimal alignment with recent state and local procurement activity. The code's nominal scope—a surgical procedure involving tissue grafting on the upper arm—does not match the medical and health services actually being solicited by state and local jurisdictions under this classification.

The most recent state and local contract opportunities tagged to this code include independent medical evaluation services for public safety pension boards, surgical benefit carve-out programs for municipal health plans, occupational medical surveillance for ferry workers, emergency and specialty care for detained youth, pharmacy benefit management, and temporary ancillary clinical staffing. These solicitations span disability determinations, Centers of Excellence networks, occupational health compliance, custody healthcare, pharmaceutical administration, and clinical temp staffing—none of which involve orthopaedic or soft-tissue surgical procedures. The issuing bodies include city retirement offices (Phoenix), municipalities (Long Beach), state transportation departments (Washington), county probation and health systems (Harris County, Santa Clara), and county boards of commissioners (Collier County). The geographic spread covers Arizona, California, Washington, Texas, and Florida. This code shows little relevant recent activity for firms positioned to deliver the surgical procedure it nominally names.